Drug intelligence / Profile preview

13C-Spirulina platensis

Development stage
Unknown
Lead developer
Cairn Diagnostics
Modality
Small Molecules
Administration
Oral
01

Overview

13C-Spirulina platensis is a diagnostic test agent developed by the Mayo Clinic for the Gastric Emptying Breath Test (GEBT). It consists of the protein-rich blue-green algae *Spirulina platensis* that has been enriched with the stable isotope carbon-13 (13C) to approximately 99% enrichment. Unlike therapeutic drugs, this agent serves as a metabolic tracer to measure the rate of gastric emptying in patients with symptoms of dyspepsia, gastroparesis, or dumping syndrome. After oral ingestion within a standardized test meal, the labeled algae remains in the stomach until it is emptied into the small intestine, where it is digested and absorbed. The 13C is then metabolized to 13CO2, which is exhaled in the breath. By measuring the ratio of 13CO2 to 12CO2 in breath samples at specific intervals, clinicians can quantitatively determine gastric emptying kinetics. This method provides a non-invasive, radiation-free, point-of-care alternative to the traditional gold-standard diagnostic, scintigraphy.

Other names
13C-Spirulina platensis GEBTCarbon-13 labeled Spirulina platensisCarbon13 labeled Spirulina platensisCarbon 13 labeled Spirulina platensis13C-Spirulina platensis Gastric Emptying Breath Test

Beyond the preview

Go deeper on 13C-Spirulina platensis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 13C-Spirulina platensis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call